Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7484-7495

  Jeyaseelan, Samithamby ^a,b   Manzer, Rizwan ^a   Young, Scott K ^a   Yamamoto, Masahiro ^c   Akira, Shizuo ^c   Mason, Robert J ^a,b   Worthen, G Scott ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UNITED STATES;

EID: 28244432857     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7484     Document Type: Article

References (51)

1. Piantadosi, C. A., and D. A, Schwanz. 2004. The acute respiratory distress syndrome. Ann. Intern. Med. 141: 460-470.
2. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, and R. Spragg. 1994. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149: 818-824.
3. Goodman, R. B., R. M. Stricter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 602-611.
4. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501.
5. Weiland, J. E., W. B. Davis, J. F. Kolter, J. R. Mohammed, P. M. Dorinsky, and J. E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133: 218-225.
6. Stricter, R. M., and S. L. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J. Invest. Med. 42: 640-651.
7. Akira, S., and K. Takeda. 2004. Toll-like receptor signaling. Nat. Rev. Immunol. 4: 499-511.
8. Zhang, P., W. R. Summer, G. J. Bagby, and S. Nelson. 2000. Innate immunity and pulmonary host defense. Immunol. Rev. 173: 39-51.
9. Da Suva Correia, J., and R. J. Ulevitch. 2002. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277: 1845-1854.
10. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukocyte Biol. 64: 25-32.
11. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R, J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748.
12. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J, Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
13. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo. T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
14. Medzhkov, R., P. Preston-Hurlburt, E. Kopp, A. Stadien, C. Chen, S. Ghosh, and C. A. Janeway. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253-258.
15. Yamamoto, M., K. Takeda, and S. Akira. 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40: 861-868.
16. Takeda, K., and S. Akira. 2003. Toll receptors and pathogen resistance. Cell Microbiol. 5: 143-153.
17. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
18. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-I- and IL-18-mediated function. Immunity 9: 143-150.
19. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H, Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIP in the MyD88-independent Toll-like receptor signaling pathway. Science 301: 640-643.
20. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira. 2003. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4: 1144-1150.
21. Yamamoto, M., S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, et al. 2002. Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4, Nature 420: 324-329.
22. Frevert, C. W., G. Matute-Bello, S. J. Skerrett, R. B. Goodman, O. Kajikawa, C. Sittipum, and T. R. Martin. 2000. Effect of CD 14 blockade in rabbits with Escherichia call pneumonia and sepsis. J. Immunol. 164: 5439-5445.
23. Chu, H. W., S. Jeyaseelan, J. G. Rino, D. R. Voelker, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin. 2005. Toll-like receptor 2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J. Immunol. 144: 5713-5719.
24. Koedel, U., B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp. H. W. Pfister, and C. J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170: 438-444.
25. Echchannaoui, H., K. Frei, C. Schnell, S. L. Leib, W. Zimmerli, and R. Landmann. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186: 798-806.
26. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971.
27. Skerrett, S. J., H. D. Liggitt, A. M. Hajjar, and C. B. Wilson. 2004. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J. Immunol 172: 3377-3381.
28. Horng, T., G. M. Barton, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2: 835-841.
29. Jeyaseelan, S., H. W. Chu, S. K. Young, and G. S. Worthen. 2004. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect. Immun. 72: 1754-1763.
30. Jeyaseelan, S., H. W. Chu, S. K. Young, M. W. Freeman, and G. S. Worthen. 2005. Distinct roles of pattern recognition receptors CD 14 and Toll-like receptor 4 in acute lung injury. Infect. Immun. 73: 7247-7256.
31. Fessler, M. B., S. K. Young, S. Jeyaseelan, P. G. Arndt, J. G. Lieber, J. A. Nick, and G. S. Worthen. 2005. A novel role for 3-hydroxy-3-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense. Am. J. Respir. Crit Care Med. 179: 606-615.
32. Nick, J. A., S. K. Young, P. G. Arndt, J. G. Lieber, B. T. Suratt, K. R. Poch, N. J. Avdi, K. C. Malcolm, C. Taube, P. M. Henson, and G. S. Worthen. 2002. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J. Immunol. 169: 5260-5269.
33. Jeyaseelan, S., R. Manzer, S. K. Young, M. Yamamoto, S. Akira, R. J. Mason, and G. S. Worthen. 2005. Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am. J. Respir. Cell Mol. 32: 531-539.
34. Arndt, P. G., S. K. Young, J. G. Lieber, M. B. Fessier, J. A. Nick, and G. S. Worthen. 2005. Inhibition of c-Jun-N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx. Am. J. Respir. Crit. Care Med. 32: 131-139.
35. Ong, E. S., X. P. Gao, N. Xu, D. Predescu, A. Rahman, M. T. Broman, D. H. Jho, and A. B. Malik. 2003. E. coli pneumonia induces CDIS-independent airway neutrophil migration in the absence of increased lung vascular permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 285: L879-L888.
36. Mizgerd, J. P., M. M. Lupa, M. S. Kogan, H. B. Warren, L. Kobzik, and G. P. Topulos. 2003. Nuclear factor-κB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. Am. J. Respir. Crit. Care Med. 168: 810-817.
37. Mason, R., J. Austyn, F. Brodsky, and S. Gordon. 1982. Monoclonal antimacrophage antibodies: human pulmonary macrophages express HLA-DR (Ia-like) antigens in culture. Am. Rev. Respir. Dis. 125: 586-593.
38. Bazan-Socha, S., A. Bukiej, C. Marcinkiewicz, and J. Musial. 2005. Integrins in pulmonary inflammatory diseases. Curr. Pharm. Des. 11: 893-901.
39. Andonegui, G., S. M. Goyert, and P. Kubes. 2002. Lipopolysaccharide- induced leukocyte-endothelial cell interactions: a role for CD14 versus Toll-like receptor 4 within microvessels. J. Immunol. 169: 2111-2119.
40. Skerrett, S. J., H. D. Liggitt, A. M. Hajjar, R. K. Ernst, S. I. Miller, and C. B. Wilson. 2004. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol. Lung Cell Mol. Physiol. 287: L143-L152.
41. Worthen, G. S., B. Schwab, E. L. Elson, and G. P. Downey. 1989. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 245: 183-186.
42. Minino, A. M., and B. L. Smith. 2001. Deaths: preliminary data for 2000. In National Vital Statistics Report, Vol. 49, pp. 1-40. National Center for Vital Statistics, Hyattsville.
43. Horng, T., G. M. Barton, R. A. Flavell, and R. Medzhitov. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
44. Williams, T. J., and P. G. Hellewell. 1992. Adhesion molecules involved in the microvascular inflammatory response. Am. Rev. Respir. Dis. 146: S45-S50.
45. Mizgerd, J. P., M. M. Lupa, and M. S. Spieker. 2004. NF-κB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation. BMC Immunol. 5: 10.
46. Mizgerd, J. P., M. R. Spieker, and C. M. Doerschuk. 2001. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coll pneumonia in mice. J. Immunol. 166: 4042-4048.
47. Mizgerd, J. P., M. M. Lupa, J. Hjoberg, J. C. Vallone, H. B. Warren, J. P. Butler, and E. S. Silverman. 2004. Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1. Am. J. Physiol. Lung Cell Mol Physiol. 286: L1302-1310.
48. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underbill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
49. Hawn, T. R., A. Verbon, K. D. Lettinga, L. P. Zhao, S. S. Li, R. J. Laws, S. J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, et al. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198: 1563-1572.
50. Rehm, S. R., G. N. Gross, and A. K. Pierce. 1980. Early bacterial clearance from murine lungs: species-dependent phagocyte response. J. Clin. Invest. 66: 194-199.
51. Andreakos, E., S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis. T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell. 2004. Distinct pathways of LPS-induced NF-κB; activation and cytokine production in human myeloid and non-myeloid cells defined by selective utilization of MyD88 and MaITIRAP. Blood 103: 2229-2237.